Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer
- PMID: 31268191
- PMCID: PMC6757121
- DOI: 10.1002/jcla.22943
Identification and diagnostic value of pleural fluid periostin and serum periostin of malignant pleural effusions in patients with non-small-cell lung cancer
Abstract
Background: Limited data are available for the diagnostic value, and the diagnostic sensitivity and specificity of pleural fluid periostin (pPOSTN) and serum periostin (sPOSTN) in malignant pleural effusion (MPE) caused by non-small-cell lung cancer (NSCLC).
Methods: We collected 84 pleural effusion samples, including 44 cases of MPE caused by NSCLC and 40 cases of benign pleural effusions (BPEs) from August 2018 to January 2019. The pPOSTN, sPOSTN, pleural fluid lactate dehydrogenase (pLDH), pleural effusion adenosine deaminase (pADA), pleural effusion total protein (pTP), pleural fluid glucose (pGLU), pleural effusion leukocyte count (pWBC), pleural effusion red cell count (pRBC), pleural effusion carbohydrate antigen 199 (pCA199), pleural fluid carbohydrate antigen 125 (pCA125), pleural effusion ferritin (pFer), serum total protein (sTP), and serum C-reactive protein (sCRP) were tested, and the obtained data were analyzed by statistical software.
Results: Compared to the BPE group, the pPOSTN level in the MPE group was observably lower, while the levels of sPOSTN, sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN increased. The receiver operating characteristic (ROC) curve showed that the area under the ROC curve (AUC) (=0.844, 0.847, 0.841) of sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN (cutoff = 11.86, 0.244, 0.015) was observably higher than other indicators for the diagnosis of MPE caused by NSCLC. Thus, the combined detection of pPOSTN, pCA125/pPOSTN, and pCA125/sCRP suggested that the AUC, sensitivity, and specificity was 0.912%, 95.45%, and 77.50% at the cutoff 0.317 and diagnostic performance was higher than sPOSTN/pADA or pCA199/pADA or pCA199/pPOSTN.
Conclusion: Combined detection of sPOSTN/pADA, pCA199/pADA, and pCA199/pPOSTN can be used as a good indicator for MPE caused by NSCLC.
Keywords: malignant pleural effusion; non-small-cell lung cancer; periostin.
© 2019 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.
Figures


Similar articles
-
Clinical value of jointly detection pleural fluid Midkine, pleural fluid adenosine deaminase, and pleural fluid carbohydrate antigen 125 in the identification of nonsmall cell lung cancer-associated malignant pleural effusion.J Clin Lab Anal. 2018 Oct;32(8):e22576. doi: 10.1002/jcla.22576. Epub 2018 May 23. J Clin Lab Anal. 2018. PMID: 29797475 Free PMC article.
-
Clinical value of combined detection of reactive oxygen species modulator 1 and adenosine deaminase in pleural effusion in the identification of NSCLC associated malignant pleural effusion.J Clin Lab Anal. 2020 Mar;34(3):e23091. doi: 10.1002/jcla.23091. Epub 2019 Nov 10. J Clin Lab Anal. 2020. PMID: 31709646 Free PMC article.
-
Clinical value of jointly detection serum lactate dehydrogenase/pleural fluid adenosine deaminase and pleural fluid carcinoembryonic antigen in the identification of malignant pleural effusion.J Clin Lab Anal. 2017 Sep;31(5):e22106. doi: 10.1002/jcla.22106. Epub 2016 Dec 15. J Clin Lab Anal. 2017. PMID: 27976800 Free PMC article.
-
Diagnostic value of survivin for malignant pleural effusion: a clinical study and meta-analysis.Int J Clin Exp Pathol. 2014 Aug 15;7(9):5880-7. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337230 Free PMC article. Review.
-
Myelomatous pleural effusion: a case series in a single institution and literature review.Korean J Lab Med. 2011 Oct;31(4):225-30. doi: 10.3343/kjlm.2011.31.4.225. Epub 2011 Oct 3. Korean J Lab Med. 2011. PMID: 22016674 Free PMC article. Review.
Cited by
-
Clinical Efficacy of Different Thoracoscopic Surgeries for Patients With Non-small Cell Lung Cancer.Front Surg. 2022 Feb 15;9:842047. doi: 10.3389/fsurg.2022.842047. eCollection 2022. Front Surg. 2022. PMID: 35242806 Free PMC article.
-
Proteomic Analysis of the Air-Way Fluid in Lung Cancer. Detection of Periostin in Bronchoalveolar Lavage (BAL).Front Oncol. 2020 Jul 3;10:1072. doi: 10.3389/fonc.2020.01072. eCollection 2020. Front Oncol. 2020. PMID: 32719746 Free PMC article.
-
Clinical analysis of prolonged viral clearance time in patients with lymphoma combined with novel coronavirus infection.Front Mol Biosci. 2023 Oct 4;10:1240175. doi: 10.3389/fmolb.2023.1240175. eCollection 2023. Front Mol Biosci. 2023. PMID: 37860581 Free PMC article.
-
Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis.J Cancer. 2020 Oct 18;11(24):7116-7126. doi: 10.7150/jca.49224. eCollection 2020. J Cancer. 2020. PMID: 33193874 Free PMC article.
-
Diagnostic value of periostin in lung cancer-related malignant pleural effusion.J Clin Lab Anal. 2022 Feb;36(2):e24179. doi: 10.1002/jcla.24179. Epub 2021 Dec 27. J Clin Lab Anal. 2022. PMID: 35152510 Free PMC article.
References
-
- Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177‐193. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69‐90. - PubMed
-
- Morgensztern D, Waqar S, Subramanian J, Trinkaus K, Govindan R. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non‐small‐cell lung cancer. J Thorac Oncol. 2012;7(10):1485‐1489. - PubMed
-
- Braunschweig R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination. Diagn Cytopathol. 2001;24(3):174‐180. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous